<- Go Home
Cantel Medical LLC
As of June 2, 2021, Cantel Medical LLC was acquired by STERIS plc. Cantel Medical LLC provides infection prevention and control products and services for the healthcare market. Its Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services, as well as microbiological testing services. Its Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. Its Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical LLC was formerly known as Cantel Medical Corp. The company was founded in 1963 and is based in Little Falls, New Jersey.
Market Cap
$3.3B
Volume
523.4K
Cash and Equivalents
$218.5M
EBITDA
$247.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$547.8M
Profit Margin
48.12%
52 Week High
$89.76
52 Week Low
$39.40
Dividend
N/A
Price / Book Value
4.09
Price / Earnings
67.80
Price / Tangible Book Value
-10.99
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$178.2M
Return on Equity
6.92%
Return on Assets
5.65
Cash and Short Term Investments
$218.5M
Debt
$958.8M
Equity
$817.2M
Revenue
$1.1B
Unlevered FCF
$181.8M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium